Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease
Movement Disorders · 2026
DOI: 10.1002/mds.70292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Sofie Slingerland und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Glucosylceramidase, Parkinson Disease, Monocytes, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Background
The GBA1 gene encodes the lysosomal enzyme glucocerebrosidase (GCase). Parkinson's disease (PD) patients carrying a GBA1 variant (GBA‐PD) exhibit faster cognitive decline, linked to cholinergic degeneration.
Objectives
The aim was to investigate whether GCase activity, measured in monocytes, correlates with cognitive dysfunction or regional brain cholinergic innervation in early‐stage PD patients.
Methods
A total of 137 PD patients underwent a complete neuropsychological assessment, blood sampling, brain magnetic resonance imaging, and 18 F‐fluoroethoxybenzovesamicol positron emission tomography (PET). Monocytic GCase activity was quantified using flow cytometry with the substrate 5‐pentafluorobenzoylamino fluorescein di‐β‐ d ‐glucopyranoside.
Results
Monocytes from GBA‐PD (n = 42) patients exhibited significant lower GCase activity ( P = 0.007) compared to those from non‐GBA‐PD individuals (n = 95). However, GCase activity did not correlate with cognition. Similarly, voxel‐wise and volume‐of‐interest PET analyses did not reveal associations with monocytic GCase activity.
Conclusions
Monocytic GCase activity does not appear to be a reliable biomarker for cognitive decline in early‐stage PD and is not linked to regional cholinergic denervation. Peripheral measurements do not reflect central processes underlying cholinergic dysfunction. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Neurology, Division of Clinical Neuropsychology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Biomedical Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Ardena Bioanalysis, Assen, The Netherlands.
ORCID-Profile: Sofie Slingerland, Sygrid van der Zee, Sven C D van Ijzendoorn
Förderung
- Michael J. Fox Foundation for Parkinson's Research
Zitieren
APA
Slingerland, S., van der Zee, S., van Ijzendoorn, S. C. D., Slomp, A. C., Boertien, J. M., Meles, S. K., Kol, A., Geerlings, M., & van Laar, T. (2026). Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70292
Vancouver
Slingerland S, van der Zee S, van Ijzendoorn SCD, Slomp AC, Boertien JM, Meles SK, et al. Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease. Movement Disorders. 2026. doi:10.1002/mds.70292
BibTeX
@article{Slingerland2026,
author = {Slingerland, Sofie and van der Zee, Sygrid and van Ijzendoorn, Sven C D and Slomp, Anne C and Boertien, Jeffrey M and Meles, Sanne K and Kol, Arjan and Geerlings, Marie and van Laar, Teus},
title = {Associations of Monocyte Glucocerebrosidase with Cognition and Cholinergic Innervation in GBA1 Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70292}
}
EUVIMED